NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 318 filers reported holding NATERA INC in Q3 2023. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,387,105 | -10.6% | 31,347 | -1.7% | 0.00% | 0.0% |
| Q2 2023 | $1,551,086 | +625.8% | 31,876 | +499.2% | 0.00% | – |
| Q4 2022 | $213,704 | -22.3% | 5,320 | -15.2% | 0.00% | – |
| Q3 2022 | $275,000 | -30.9% | 6,275 | +47.1% | 0.00% | – |
| Q4 2021 | $398,000 | -30.8% | 4,267 | -17.4% | 0.00% | -100.0% |
| Q3 2021 | $575,000 | -8.1% | 5,164 | -6.3% | 0.00% | 0.0% |
| Q2 2021 | $626,000 | -71.0% | 5,511 | -74.1% | 0.00% | -50.0% |
| Q1 2021 | $2,159,000 | +1.3% | 21,261 | -0.7% | 0.00% | 0.0% |
| Q4 2020 | $2,131,000 | +42.7% | 21,417 | +3.6% | 0.00% | 0.0% |
| Q3 2020 | $1,493,000 | +246.4% | 20,668 | +139.2% | 0.00% | +100.0% |
| Q2 2020 | $431,000 | +55.6% | 8,640 | +5.1% | 0.00% | – |
| Q4 2019 | $277,000 | -36.5% | 8,218 | -48.0% | 0.00% | -100.0% |
| Q2 2019 | $436,000 | – | 15,815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,104,581 | $48,403,000 | 19.54% |
| Kynam Capital Management, LP | 2,018,360 | $88,445,000 | 18.64% |
| Foresite Capital Management III, LLC | 159,160 | $6,974,000 | 18.41% |
| Sofinnova Investments, Inc. | 3,102,960 | $135,972,000 | 7.91% |
| Eagle Health Investments LP | 595,994 | $26,116,000 | 5.99% |
| Eversept Partners, LP | 1,425,602 | $62,469,880 | 5.41% |
| Lagoda Investment Management, L.P. | 159,220 | $6,977,000 | 4.96% |
| Hudson Executive Capital LP | 588,886 | $25,805,000 | 3.70% |
| Parian Global Management LP | 24,000 | $1,052,000 | 3.42% |
| BRANDYWINE MANAGERS, LLC | 21,534 | $944,000 | 3.10% |